Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Operating Leases (2021 - 2025)

Zymeworks' Operating Leases history spans 5 years, with the latest figure at $14.8 million for Q4 2025.

  • On a quarterly basis, Operating Leases fell 20.17% to $14.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.8 million, a 20.17% decrease, with the full-year FY2025 number at $14.8 million, down 20.17% from a year prior.
  • Operating Leases hit $14.8 million in Q4 2025 for Zymeworks, down from $15.5 million in the prior quarter.
  • Over the last five years, Operating Leases for ZYME hit a ceiling of $32.2 million in Q4 2021 and a floor of $14.8 million in Q4 2025.
  • Historically, Operating Leases has averaged $22.3 million across 5 years, with a median of $22.4 million in 2023.
  • The widest YoY moves for Operating Leases: up 7.02% in 2025, down 39.62% in 2025.
  • Tracing ZYME's Operating Leases over 5 years: stood at $32.2 million in 2021, then decreased by 13.17% to $28.0 million in 2022, then dropped by 20.08% to $22.4 million in 2023, then dropped by 17.14% to $18.5 million in 2024, then fell by 20.17% to $14.8 million in 2025.
  • Business Quant data shows Operating Leases for ZYME at $14.8 million in Q4 2025, $15.5 million in Q3 2025, and $18.7 million in Q2 2025.